Clinical features and survival of patients with indolent systemic mastocytosis defined by the updated WHO classification

ALLERGY

Trizuljak, J; Sperr, WR; Nekvindova, L; Elberink, HO; Gleixner, KV; Gorska, A; Lange, M; Hartmann, K; Illerhaus, A; Bonifacio, M; Perkins, C; Elena, C; Malcovati, L; Fortina, AB; Shoumariyeh, K; Jawhar, M; Zanotti, R; Bonadonna, P; Caroppo, F; Zink, A; Triggiani, M; Parente, R; von Bubnoff, N; Yavuz, AS; Hagglund, H; Mattsson, M; Panse, J; Jakel, N; Kilbertus, A; Hermine, O; Arock, M; Fuchs, D; Sabato, V; Brockow, K; Bretterklieber, A; Niedoszytko, M; van Anrooij, B; Reiter, A; Gotlib, J; Kluin-Nelemans, HC; Mayer, J; Doubek, M; Valent, P, 2020: Clinical features and survival of patients with indolent systemic mastocytosis defined by the updated WHO classification. ALLERGY 75(8), p. 1927 - 1938, doi: 10.1111/all.14248

Research Groups:

• Medical Genomics - Šárka Pospíšilová

CEITEC authors:

• Jakub Trizuljak
• Prof. Jiří Mayer
• Prof. Michael Doubek, Ph.D.